Login
Home
About Us
Services
Advances & More News
Medical News
Contact Us
Medical News
AAAAI Congress 2021: Omalizumab Improves Sleep Outcomes with Nasal Polyposis Over 76 Weeks
Omalizumab (Xolair) benefitted sleep disturbance among patients with nasal polyposis over a span of 76 weeks, ...
read more
Broadcasting from AAAAI 2021 Congress: Managing Asthmatic Fears During COVID-19
As covered by Lakiea Wright, MD, in a previous interview segment with HCPLive® during the American ...
read more
AAAAI 2021 Research Suggests No Raised Risk of COVID-19 Severity with Asthma
A collection of articles published at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 ...
read more
AAAAI Congress 2021: What Is Needed to Improve Pediatric Asthma Controller Therapy Adherence
At the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions this weekend, a ...
read more
From AAAAI Congress 2021: Revised Anaphylaxis Diagnostic Guidelines Seen as an Improvement
New research shows a recently revised diagnostic criteria is sufficient for emergency departments to identify and ...
read more
Broadcasting from AAAAI Congress 2021: Masks Deemed Safe for Asthma Patients
Masks have become a key mitigation piece in the fight to stop the spread of COVID-19. However, ...
read more
AAAAI Congress 2021: Sublingual Immunotherapy May Provide Peanut Allergy Desensitization in Toddlers
Sustained unresponsiveness, a pivotal, sought-after benchmark in allergic immunotherapy research, may be achievable with early initiation ...
read more
From AAAAI Congress 2021, Study: Pediatric Adherence to Drugs Treating Severe Asthma is About 57%
Late-breaking data presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions ...
read more
1
2
3
4
5
...
Next
Last